147 related articles for article (PubMed ID: 14965064)
21. [Use of hypolipemic agents in Spain, 1987-2000].
Siles Gutiérrez M; Goldaracena Tanco M; Avila Muñoz L; Sánchez-Eznarriaga BC
Rev Esp Salud Publica; 2001; 75(2):129-41. PubMed ID: 11400423
[TBL] [Abstract][Full Text] [Related]
22. Trends in consumption of psychiatric drugs in Serbia and Montenegro 2000-2004.
Divac N; Tosevski DL; Babić D; Djurić D; Prostran M; Samardzić R
Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):835-8. PubMed ID: 16958148
[TBL] [Abstract][Full Text] [Related]
23. Antipsychotic use in older adults with Parkinson's disease.
Marras C; Kopp A; Qiu F; Lang AE; Sykora K; Shulman KI; Rochon PA
Mov Disord; 2007 Feb; 22(3):319-23. PubMed ID: 17149718
[TBL] [Abstract][Full Text] [Related]
24. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
[TBL] [Abstract][Full Text] [Related]
25. [Drug consumption in diabetes mellitus (III). Trends of hypoglycemic agents use and consumption in Tarragona, Catalonia, and Spain (1988- 1991). Group for the Study of Diabetes in Tarragona].
Costa B; Hernández JM
Med Clin (Barc); 1993 Apr; 100(15):571-5. PubMed ID: 8497145
[TBL] [Abstract][Full Text] [Related]
26. The use of conventional antipsychotic medications for patients with schizophrenia in a medicaid population: therapeutic and cost outcomes over 2 years.
McCombs JS; Luo M; Johnstone BM; Shi L
Value Health; 2000; 3(3):222-31. PubMed ID: 16464186
[TBL] [Abstract][Full Text] [Related]
27. New users of antipsychotic medications among children enrolled in TennCare.
Cooper WO; Hickson GB; Fuchs C; Arbogast PG; Ray WA
Arch Pediatr Adolesc Med; 2004 Aug; 158(8):753-9. PubMed ID: 15289247
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
29. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
30. Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine.
Garcia del Pozo J; Carvajal A; Viloria JM; Velasco A; Garcia del Pozo V
Eur J Clin Pharmacol; 2008 Apr; 64(4):411-5. PubMed ID: 18157671
[TBL] [Abstract][Full Text] [Related]
31. [Geographic variability in prescribing antibiotics in the pediatric population of Castille and León during 2001-2005].
Vázquez ME; Pastor E; Bachiller MR; Vázquez MJ; Eiros JM
Rev Esp Quimioter; 2006 Dec; 19(4):342-8. PubMed ID: 17235403
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of first- and second-generation antipsychotic agents in Lombardy, Italy.
Percudani M; Barbui C; Fortino I; Petrovich L
Pharmacopsychiatry; 2005 May; 38(3):128-31. PubMed ID: 15902584
[TBL] [Abstract][Full Text] [Related]
33. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States.
Sun SX; Liu GG; Christensen DB; Fu AZ
Curr Med Res Opin; 2007 Oct; 23(10):2305-12. PubMed ID: 17697454
[TBL] [Abstract][Full Text] [Related]
34. Patterns of medication use in the immigrant population resident in Spain: associated factors.
Carrasco-Garrido P; Jiménez-García R; Hernández Barrera V; López de Andrés A; Gil de Miguel A
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):743-50. PubMed ID: 19479714
[TBL] [Abstract][Full Text] [Related]
35. Prevalence, correlates, and disease patterns of antipsychotic use in Taiwan.
Chien IC; Hsu JH; Bih SH; Lin CH; Chou YJ; Lee CH; Chou P
Psychiatry Clin Neurosci; 2008 Dec; 62(6):677-84. PubMed ID: 19068004
[TBL] [Abstract][Full Text] [Related]
36. [Antidepressant and antipsychotic drug prescribing in Lombardy].
Percudani M; Barbui C; Fortino I; Tansella M; Petrovich L
Epidemiol Psichiatr Soc; 2006; 15(1):59-70. PubMed ID: 16584104
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
38. Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy.
Andretta M; Ciuna A; Corbari L; Cipriani A; Barbui C
Soc Psychiatry Psychiatr Epidemiol; 2005 Jan; 40(1):72-7. PubMed ID: 15624078
[TBL] [Abstract][Full Text] [Related]
39. Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit.
Lerma-Carrillo I; de Pablo Brühlmann S; del Pozo ML; Pascual-Pinazo F; Molina JD; Baca-García E
Clin Neuropharmacol; 2008; 31(6):319-32. PubMed ID: 19050409
[TBL] [Abstract][Full Text] [Related]
40. [The prevalence and pharmacological cost of Parkinson's disease in Spain].
Abasolo-Osinaga E; Abecia-Inchaurregui LC; Fernández-Díaz E; Barcenilla-Laguna A; Bañares-Onraita T
Rev Neurol; 2006 Dec 1-15; 43(11):641-5. PubMed ID: 17133323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
